October 4, 2018
David Enloe, CEO of Ajinomoto Bio-Pharma Services, is getting his company in shape for future acquisitions. He recently expanded his company’s San Diego facilities.
Stories this photo appears in:
Japanese food and drug manufacturing giant Ajinomoto Group is reorganizing, placing three disparate drug-making businesses on three continents under one umbrella.